Marketing channel feed

HHS says it may re­vis­it an­ti-obe­si­ty drug poli­cies af­ter drop­ping Biden-era pro­pos­al

Last month
Pharma
Law

RFK Jr. has long crit­i­cized drug ads. He just slashed the FDA of­fice that reg­u­lates them

Last month
Pharma
FDA+

J&J touts new sur­vival da­ta pit­ting lung can­cer com­bo against As­traZeneca's ri­val

Last month
R&D
Pharma

No­vo Nordisk slash­es We­govy price by near­ly two-thirds for cash-pay­ing pa­tients

2 months ago
Pharma

Mis­lead­ing ex­hib­it booth pan­el lands NJ drug­mak­er an un­ti­tled let­ter from FDA

2 months ago
FDA+

Eli Lil­ly ex­pands Zep­bound sin­gle-dose vial op­tions at low­er price

2 months ago
Pharma

J&J's new can­cer com­bo beats As­traZeneca's Tagris­so on sur­vival in lung tri­al

4 months ago
Pharma

Drugs are ap­proved — and made avail­able — faster in US than most of EU, da­ta show

5 months ago
Pharma
FDA+

No­var­tis bol­sters Fab­hal­ta da­ta in com­pe­ti­tion with As­traZeneca

5 months ago
R&D

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

5 months ago
Pharma

FDA says Merz's so­cial me­dia pro­mo­tion with Nate Berkus is 'mis­lead­ing'

5 months ago
Pharma

Val­ne­va and Pfiz­er eye 2027 launch for part­nered Ly­me dis­ease vac­cine

7 months ago
Pharma

UK watch­dog crit­i­cizes Mod­er­na for Covid-19 tri­al's use of What­sApp to dan­gle pay­ments to chil­dren

7 months ago
Pharma

FDA crit­i­cizes Ab­b­Vie's 'mis­lead­ing' ad with Ser­e­na Williams

8 months ago
Pharma
FDA+

Up­dat­ed: Madri­gal fi­nal­ly re­veals first wave of sales for MASH drug Rezd­if­fra

9 months ago
Pharma

RSV mar­ket pres­sure leads to slow­er launch for Mod­er­na's vac­cine

9 months ago
Pharma

Verona inks fi­nanc­ing deal worth up to $650M ahead of COPD de­ci­sion

Last year
Financing

From the ed­i­tor: Our fi­nal edi­tion of End­points Mar­ket­ingRx

Last year
Editor's note

Mar­ket­ingRx roundup: Mod­er­na de­buts so­cial me­dia sci­ence se­ries; Boehringer ex­pands NY men­tal health ex­hib­it

Last year
Pharma

Re­al Chem­istry de­buts a one-stop dash­board for all things GLP-1

Last year
Pharma

Phar­ma rep­u­ta­tion slips among pa­tient ad­vo­ca­cy groups, ac­cord­ing to an­nu­al sur­vey

Last year
Pharma

Sanofi and Re­gen­eron de­but next gen­er­a­tion in Dupix­en­t's asth­ma cam­paign

Last year
Pharma

Ipsen match­es rare dis­ease and Tik­Tok in­flu­encers to cre­ate con­nec­tions

Last year
Pharma

FDA re­vis­es guid­ance on biosim­i­lar pro­mo­tion­al la­bels and ad­ver­tis­ing

Last year
FDA+
1234 Next page Last page
A service from the Financial Times